... Fund Management LLC bought a new position in CymaBay Therapeutics during the third quarter worth about $404,000. Ardsley Advisory Partners increased its position in CymaBay Therapeutics by 66.2% during the second quarter. Ardsley Advisory Partners ...
http://ift.tt/2lnjfEg
No comments:
Post a Comment